Journal article
Authors list: Sklyarova, AS; Rodionov, VN; Parsons, CG; Quack, G; Schreiner, PR; Fokin, AA
Publication year: 2013
Pages: 360-366
Journal: Medicinal Chemistry Research
Volume number: 22
Issue number: 1
DOI Link: https://doi.org/10.1007/s00044-012-0029-7
Publisher: Springer
Computational modeling demonstrates that the van-der-Waals surfaces of homocubyl amines are similar to that of the neuroprotector Memantine®. Utilizing readily available precursors we report the preparation of a series of homological cubylamines, namely
Abstract:
pentacyclo[6.3.0.02,6.03,10.05,9]undecyl-4-amine (trishomocubyl-4-amine, 2), pentacyclo[5.3.0.02,5.03,9.04,8]decyl-10-amine (bishomocubyl-10-amine, 3), pentacyclo[4.3.0.02,5.03,8.04,7]nonyl-9-amine (homocubyl-9-amine, 4), and pentacyclo[4.2.0.02,5.03,8.04,7]octyl-1-amine (cubylamine, 5). The hydrochlorides of amines 2–5 show pronounced affinity for the (+)MK-801 channel binding site, and it seems likely that these compounds would act as very fast voltage-dependent NMDA receptor antagonists.
Citation Styles
Harvard Citation style: Sklyarova, A., Rodionov, V., Parsons, C., Quack, G., Schreiner, P. and Fokin, A. (2013) Preparation and testing of homocubyl amines as therapeutic NMDA receptor antagonists, Medicinal Chemistry Research, 22(1), pp. 360-366. https://doi.org/10.1007/s00044-012-0029-7
APA Citation style: Sklyarova, A., Rodionov, V., Parsons, C., Quack, G., Schreiner, P., & Fokin, A. (2013). Preparation and testing of homocubyl amines as therapeutic NMDA receptor antagonists. Medicinal Chemistry Research. 22(1), 360-366. https://doi.org/10.1007/s00044-012-0029-7